Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

157.20
Delayed Data
As of Feb 27
 +0.25 / +0.16%
Today’s Change
86.00
Today|||52-Week Range
172.98
+36.77%
Year-to-Date

Today’s Trading

Previous close156.95
Today’s open156.82
Day’s range156.71 - 157.40
Volume2,654,769
Average volume (3 months)2,457,084
Market cap$10.0B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+8.19%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+26.98%
P/E ratioNM
Price/Sales5.95
Price/Book13.33

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.98-1.38%
JAZZJazz Pharmaceuticals...-5.10-2.91%
MDVNMedivation Inc-2.21-1.85%
RDYDr.Reddy's Laborator...-0.02-0.04%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Thomas W. D'Alonzo
COO, SVP-Corporate Compliance &
General Counsel
William C. Bertrand
Corporate headquarters
Raleigh, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account